Dr. Jeffrey Gelfand, a Senior Scientific Advisor at the Vaccine and Immunotherapy Center, has had a manuscript accepted in the Journal of Infectious Disease entitled, ‘Clofazimine for babesiosis: preclinical data support a clinical trial’.
Clofazimine for babesiosis: preclinical data support a clinical trial
